Tamer Khayal
Corporate Officer/Principal bei TRANSMEDICS GROUP, INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Tamer I.
Khayal is currently the Chief Medical Officer at TransMedics, Inc. since 2013 and the Chief Commercial Officer at TransMedics Group, Inc. since 2018.
Previously, he worked as the Director-Clinical Affairs at Zentiva Group as.
Dr. Khayal obtained his doctorate degree from KasrAlAiny School of Medicine in 1993.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
TRANSMEDICS GROUP, INC.
0,16% | 09.04.2024 | 51 012 ( 0,16% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Tamer Khayal
Unternehmen | Position | Beginn |
---|---|---|
TRANSMEDICS GROUP, INC. | Corporate Officer/Principal | 01.01.2018 |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Chief Tech/Sci/R&D Officer | 01.05.2001 |
Ehemalige bekannte Positionen von Tamer Khayal
Unternehmen | Position | Ende |
---|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Tamer Khayal
KasrAlAiny School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TRANSMEDICS GROUP, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Health Technology |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Health Technology |